These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22768660)

  • 21. Neonatal screening for congenital adrenal hyperplasia: transitory elevation of 17-hydroxyprogesterone.
    Huidobro Fernández B; Echeverria Fernández M; Dulin Iñiguez E; Ezquieta Zubicaray B; Roldán Martín MB; Rodríguez Arnao MD; Rodríguez Sánchez A
    J Pediatr Endocrinol Metab; 2011; 24(3-4):155-62. PubMed ID: 21648283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
    BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum 17 alpha hydroxyprogesterone in normal full term and preterm vs sick preterm and full term newborns in a tertiary hospital.
    Chennuri VS; Mithbawkar SM; Mokal RA; Desai MP
    Indian J Pediatr; 2013 Jan; 80(1):21-5. PubMed ID: 22865354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
    al Saedi S; Dean H; Dent W; Stockl E; Cronin C
    Pediatrics; 1996 Jan; 97(1):100-2. PubMed ID: 8545200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of gender, birth weight and gestational age on serum 17-hydroxyprogesterone concentration and distribution among neonates in Saudi Arabia.
    al-Nuaim AR; Abdullah MA; Stevens B; Zain M
    Indian J Pediatr; 1995; 62(5):605-9. PubMed ID: 10829930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Do we need congenital adrenal hyperplasia screening for premature infants?].
    Huet F; Godefroy A; Cheillan D; Somma C; Roussey M
    Arch Pediatr; 2014 Feb; 21(2):233-6. PubMed ID: 24361036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.
    Tsuji A; Konishi K; Hasegawa S; Anazawa A; Onishi T; Ono M; Morio T; Kitagawa T; Kashimada K
    BMC Pediatr; 2015 Dec; 15():209. PubMed ID: 26671474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal screening program for congenital adrenal hyperplasia: adjustments to the recall protocol.
    Gruñeiro-Papendieck L; Prieto L; Chiesa A; Bengolea S; Bossi G; Bergadá C
    Horm Res; 2001; 55(6):271-7. PubMed ID: 11805430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cortisol in dried blood screening specimens from newborns with raised 17-hydroxyprogesterone and congenital adrenal hyperplasia.
    Mitchell ML; Hermos RJ
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):757-60. PubMed ID: 9713565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterozygosis for CYP21A2 mutation considered as 21-hydroxylase deficiency in neonatal screening.
    Soardi FC; Lemos-Marini SH; Coeli FB; Maturana VG; Silva MD; Bernardi RD; Justo GZ; de-Mello MP
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1388-92. PubMed ID: 19169499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional glucocorticoid receptor gene variants do not underlie the high variability of 17-hydroxyprogesterone screening values in healthy newborns.
    Schreiner F; Tozakidou M; Maslak R; Holtkamp U; Peter M; Gohlke B; Woelfle J
    Eur J Endocrinol; 2009 Apr; 160(4):667-73. PubMed ID: 19174530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
    Fingerhut R
    Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
    Varness TS; Allen DB; Hoffman GL
    J Pediatr; 2005 Oct; 147(4):493-8. PubMed ID: 16227036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
    Gu X; Zhou J; Ye J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):16-8. PubMed ID: 11955341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of Newborn Screening for Congenital Adrenal Hyperplasia at Two Time Points.
    Eshragh N; Doan LV; Connelly KJ; Denniston S; Willis S; LaFranchi SH
    Horm Res Paediatr; 2020; 93(2):128-136. PubMed ID: 32659761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cortisol assay in dried blood spots to reduce false positive rate in congenital adrenal hyperplasia screening.
    Brossaud J; Barat P; Fagour L; Corcuff JB
    Clin Chim Acta; 2012 Aug; 413(15-16):1306-7. PubMed ID: 22561187
    [No Abstract]   [Full Text] [Related]  

  • 37. Analysis of blood spot 17 alpha-hydroxyprogesterone concentration in premature infants--proposal for cut-off limits in screening for congenital adrenal hyperplasia.
    Ohkubo S; Shimozawa K; Matsumoto M; Kitagawa T
    Acta Paediatr Jpn; 1992 Apr; 34(2):126-33. PubMed ID: 1621517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value.
    Olgemöller B; Roscher AA; Liebl B; Fingerhut R
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5790-4. PubMed ID: 14671170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of monoclonal antibodies against 17α-hydroxyprogesterone for newborn screening of congenital adrenal hyperplasia.
    Morejón García G; García de la Rosa I; González Reyes EC; Rubio Torres A; Quintana Guerra JM; Hernández Marín M; Pérez Mora PL; Feal Carballo S; Lafita Delfino Y; Pupo Infante M; Castells Martínez EM; Rosabal Poloshkov A; Hernández Pérez L
    Clin Chim Acta; 2018 Oct; 485():311-315. PubMed ID: 30006291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.
    Hayashi GY; Carvalho DF; de Miranda MC; Faure C; Vallejos C; Brito VN; Rodrigues AS; Madureira G; Mendonca BB; Bachega TA
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):480-487. PubMed ID: 27978607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.